North America Testosterone Replacement Therapy Market Size, Share & Trends Analysis Report By End User (Clinics, and Hospital), By Product Type (Injectables, Topical, and Others), By Active, By Country and Growth Forecast, 2024 - 2031

The North America Testosterone Replacement Therapy Market would witness market growth of 3.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Testosterone Replacement Therapy Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $734.8 million by 2031. The Canada market is experiencing a CAGR of 5.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4.9% during (2024 - 2031).

Professional organizations and medical societies have developed guidelines and recommendations for the diagnosis and management of hypogonadism. These guidelines provide evidence-based approaches to TRT initiation, monitoring, and dose adjustment, helping healthcare providers make informed treatment decisions and optimize patient outcomes. Also, healthcare providers, patient advocacy groups, and pharmaceutical companies have undertaken efforts to raise awareness about hypogonadism and the benefits of TRT. Increased awareness has led to higher rates of diagnosis and treatment initiation among affected individuals who may have previously been unaware of their condition or hesitant to seek medical attention for their symptoms.

Additionally, the testosterone replacement therapy market is influenced by various trends that shape its landscape, including advancements in treatment options, evolving patient preferences, regulatory changes, and shifts in healthcare delivery models. For example, there is a growing trend towards personalized medicine in the testosterone replacement therapy market, with healthcare providers adopting individualized treatment approaches based on patient-specific factors such as age, symptoms, comorbidities, and treatment goals. Personalized medicine allows for tailored TRT regimens, including the selection of appropriate formulations, dosages, and administration routes, to optimize therapeutic outcomes and minimize side effects for each patient.

Smoking is associated with lower testosterone levels in men, which can contribute to the development of hypogonadism or testosterone deficiency. As smoking rates increase in Canada, there may be a corresponding rise in the prevalence of hypogonadism among male smokers. This increase in the number of individuals with testosterone deficiency could lead to greater demand for TRT to address hormone imbalances and associated symptoms. Therefore, the high rates of smokers and the prevalence of obesity is propelling the growth of the market.

Free Valuable Insights: The Testosterone Replacement Therapy Market is Predict to reach USD 2.5 billion by 2031, at a CAGR of 4.1%

Based on End User, the market is segmented into Clinics, and Hospital. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Endo International PLC
• AbbVie, Inc.
• Pfizer, Inc.
• Eli Lilly And Company
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals, Inc.
• Ferring Holdings SA
• Marius Pharmaceuticals LLC
• Besins Healthcare Monaco S.A.M.
• Acrux Limited

North America Testosterone Replacement Therapy Market Report Segmentation

By End User

• Clinics
• Hospital

By Product Type

• Injectables
• Topical
• Others

By Active ingredient

• Testosterone Cypionate
• Testosterone Undecanoate
• Testosterone Enanthate
• Testosterone
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Testosterone Replacement Therapy Market, by End User
1.4.2 North America Testosterone Replacement Therapy Market, by Product Type
1.4.3 North America Testosterone Replacement Therapy Market, by Active ingredient
1.4.4 North America Testosterone Replacement Therapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. North America Testosterone Replacement Therapy Market by End User
4.1 North America Clinics Market by Region
4.2 North America Hospital Market by Region

Chapter 5. North America Testosterone Replacement Therapy Market by Product Type
5.1 North America Injectables Market by Country
5.2 North America Topical Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Testosterone Replacement Therapy Market by Active ingredients
6.1 North America Testosterone Cypionate Market by Country
6.2 North America Testosterone Undecanoate Market by Country
6.3 North America Testosterone Enanthate Market by Country
6.4 North America Testosterone Market by Country
6.5 North America Others Market by Country

Chapter 7. North America Testosterone Replacement Therapy Market by Country
7.1 US Testosterone Replacement Therapy Market
7.1.1 US Testosterone Replacement Therapy Market by End User
7.1.2 US Testosterone Replacement Therapy Market by Product Type
7.1.3 US Testosterone Replacement Therapy Market by Active ingredients
7.2 Canada Testosterone Replacement Therapy Market
7.2.1 Canada Testosterone Replacement Therapy Market by End User
7.2.2 Canada Testosterone Replacement Therapy Market by Product Type
7.2.3 Canada Testosterone Replacement Therapy Market by Active ingredients
7.3 Mexico Testosterone Replacement Therapy Market
7.3.1 Mexico Testosterone Replacement Therapy Market by End User
7.3.2 Mexico Testosterone Replacement Therapy Market by Product Type
7.3.3 Mexico Testosterone Replacement Therapy Market by Active ingredients
7.4 Rest of North America Testosterone Replacement Therapy Market
7.4.1 Rest of North America Testosterone Replacement Therapy Market by End User
7.4.2 Rest of North America Testosterone Replacement Therapy Market by Product Type
7.4.3 Rest of North America Testosterone Replacement Therapy Market by Active ingredients

Chapter 8. Company Profiles
8.1 Endo International PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 AbbVie, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Pfizer, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Eli Lilly And Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Amneal Pharmaceuticals, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Ferring Holdings SA
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research and Development Expense
8.7.5 SWOT Analysis
8.8 Marius Pharmaceuticals LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Trials & Approvals:
8.9 Besins Healthcare Monaco S.A.M.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Geographical Expansions:
8.10. Acrux Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 North America Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
TABLE 2 North America Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
TABLE 3 North America Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
TABLE 4 North America Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
TABLE 5 North America Clinics Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Clinics Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Hospital Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Hospital Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
TABLE 10 North America Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
TABLE 11 North America Injectables Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Injectables Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Topical Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Topical Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
TABLE 18 North America Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
TABLE 19 North America Testosterone Cypionate Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Testosterone Cypionate Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Testosterone Undecanoate Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Testosterone Undecanoate Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Testosterone Enanthate Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Testosterone Enanthate Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Testosterone Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Testosterone Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Testosterone Replacement Therapy Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Testosterone Replacement Therapy Market by Country, 2024 - 2031, USD Million
TABLE 31 US Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
TABLE 32 US Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
TABLE 33 US Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
TABLE 34 US Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
TABLE 35 US Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
TABLE 36 US Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
TABLE 37 US Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
TABLE 38 US Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
TABLE 39 Canada Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
TABLE 40 Canada Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
TABLE 41 Canada Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
TABLE 42 Canada Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
TABLE 43 Canada Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
TABLE 44 Canada Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
TABLE 45 Canada Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
TABLE 46 Canada Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
TABLE 47 Mexico Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
TABLE 48 Mexico Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
TABLE 49 Mexico Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
TABLE 50 Mexico Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
TABLE 51 Mexico Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
TABLE 52 Mexico Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
TABLE 53 Mexico Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
TABLE 54 Mexico Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
TABLE 55 Rest of North America Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
TABLE 56 Rest of North America Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
TABLE 57 Rest of North America Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
TABLE 58 Rest of North America Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
TABLE 59 Rest of North America Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
TABLE 60 Rest of North America Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
TABLE 61 Rest of North America Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
TABLE 62 Rest of North America Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
TABLE 63 Key Information – Endo International PLC
TABLE 64 Key information – AbbVie, Inc.
TABLE 65 Key Information – Pfizer, Inc.
TABLE 66 Key Information – Eli Lilly And Company
TABLE 67 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 68 Key Information – Amneal Pharmaceuticals, INc.
TABLE 69 key information – Ferring Holdings SA
TABLE 70 Key Information – Marius Pharmaceuticals LLC
TABLE 71 Key Information – Besins Healthcare Monaco S.A.M.
TABLE 72 Key Information – Acrux Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Testosterone Replacement Therapy Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Testosterone Replacement Therapy Market
FIG 4 Porter’s Five Forces Analysis - Testosterone Replacement Therapy Market
FIG 5 North America Testosterone Replacement Therapy Market share by End User, 2023
FIG 6 North America Testosterone Replacement Therapy Market share by End User, 2031
FIG 7 North America Testosterone Replacement Therapy Market by End User, 2020 - 2031, USD Million
FIG 8 North America Testosterone Replacement Therapy Market share by Product Type, 2023
FIG 9 North America Testosterone Replacement Therapy Market share by Product Type, 2031
FIG 10 North America Testosterone Replacement Therapy Market by Product Type, 2020 - 2031, USD Million
FIG 11 North America Testosterone Replacement Therapy Market share by Active ingredients, 2023
FIG 12 North America Testosterone Replacement Therapy Market share by Active ingredients, 2031
FIG 13 North America Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2031, USD Million
FIG 14 North America Testosterone Replacement Therapy Market share by Country, 2023
FIG 15 North America Testosterone Replacement Therapy Market share by Country, 2031
FIG 16 North America Testosterone Replacement Therapy Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Endo International PLC
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 SWOT Analysis: Pfizer, Inc.
FIG 20 Swot Analysis: Eli Lilly And Company
FIG 21 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 22 SWOT Analysis: AMNEAL PHARMACEUTICALS, INC.
FIG 23 Swot Analysis: Ferring Holdings SA
FIG 24 Swot Analysis: Acrux Limited